Keith Murphy's Contact Details
- Phone Number
- (612) 516-****
- Location
- Los Angeles Metropolitan Area
- Company
- Viscient Biosciences
- Company Address
- San Diego CA
- Social networks
About Keith Murphy
Keith Murphy, Chief Executive Officer and President, is a veteran of biotechnology startup Alkermes, Inc, where he played a central role on the development team for their first approved product, Nutropin (hGH) Depot. He moved to Amgen in 1997 and developed several other novel formulation and device products. He has 17 years of experience in biotechnology, including serving in Product Strategy and Director of Process Development roles at Amgen. His 10 years at Amgen included four years as Global Operations Leader for the largest development program in Amgen's history, Phase 3 osteoporosis/bone cancer drug denosumab. He holds a BS in Chemical Engineering from MIT, and is an alumnus of the UCLA Anderson School of Management.
Keith Murphy's Current Workplace
- Headquarters
- 3550 General Atomics Court, San Diego CA
- Website
- viscientbiosciences.com
- Phone
- (921) 21-*****
- Revenue
- $3B
- Employees
- 6
- Founded in
- 2017
- Industry
- Materials/Manufacturing
- SIC Code
-
8731 - Commercial Physical and Biological Research
Other People Named Keith Murphy
Match relevance is determined by profile alignment with job title and location, profession and industry, or users sharing the same last name.
Raleigh-Durham-Chapel Hill Area
Director of Preclinical Sales, North America - HBIO - Harvard Bioscience at Harvard Bioscience
- Biotechnology
- Pharmaceutical
- Therapeutics
Boston, Massachusetts, United States
Vice President of Quality and Delivery at Delphi Technology
- Software
- Software Engineering
FAQ
Phone: (612) 516-****